An exploratory study of Carduus marianus in cases of fatty liver

An exploratory study of Carduus Marianus in cases of fatty liver - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056237

Enrollment

Registered

2023-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: homoeopathic potentized medicine Carduus marianus: Homoeopathic medicine Carduus marianus in potency 6C, 30C will be given in form of globules size 40, dose and repetition as per need o

Eligibility

Inclusion criteria

Inclusion criteria: 1. Those patient whose ultrasonography shows any gradation of fatty liver. 2. Cases of fatty liver with presence of at least 3 symptoms of carduus marianus mentioned in homoeopathic materia medica. 3. Patients giving consent for the study. 4. Patients symptoms corresponding to carduus marianus. 5. Both males and females of 18-65 years age group. 6. Diagnosed cases of fatty liver, taking treatment from other systems of medicine, feeling no relief and seeking homoeopathic treatment.

Exclusion criteria

Exclusion criteria: 1. Females, who want to conceive, are pregnant or lactating. 2. Patients with any other severe systemic disorder. 3. Patients pursuing other treatment and are not willing to leave it. 4. Fatty liver complicated with any other serious disease. 5. Cases that need surgical intervention. 6. The cases requiring emergency treatment. 7. Cases of fatty liver grade IV as it a advance stage and present with other systemic disorder.

Design outcomes

Primary

Measure	Time frame
1 From this study, we expect that carduus marianus will give beneficial result in treatment of fatty liver cases. 2 Beneficiary will be the patients who will receive better treatment strategy as per shown in the result of study. 3 Clinical literature available on fatty liver will be enriched by this study & the results definiated to the fraternity unbiasedly. 4 This will be useful in enriching to the existing literature of materia medica, improve the knowledge of clinicians and will encourage future researches.Timepoint: The study will be undertaken for a period of 12 months, out of which cases will be registered in first 4 months so that post ultrasonography report would be assessed after 8 months interval.	—

Measure

Time frame

1 From this study, we expect that carduus marianus will give beneficial result in treatment of fatty liver cases. 2 Beneficiary will be the patients who will receive better treatment strategy as per shown in the result of study. 3 Clinical literature available on fatty liver will be enriched by this study & the results definiated to the fraternity unbiasedly. 4 This will be useful in enriching to the existing literature of materia medica, improve the knowledge of clinicians and will encourage future researches.Timepoint: The study will be undertaken for a period of 12 months, out of which cases will be registered in first 4 months so that post ultrasonography report would be assessed after 8 months interval.

—

Secondary

Measure	Time frame
To explore the effect of carduus marianus in cases of fatty liver.Timepoint: 12 months	—

Countries

India

Contacts

Public ContactSatya prakash Singh

Dr MPK Homoeopathic Medical College Hospital and Research Centre

drsoniatuteja@yahoo.in9530454132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026